Filing Details
- Accession Number:
- 0001179110-18-001378
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-01 17:50:01
- Reporting Period:
- 2018-01-31
- Accepted Time:
- 2018-02-01 17:50:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1492289 | J Brian Blaser | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2018-01-31 | 27,733 | $22.39 | 156,587 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 890 | $62.24 | 155,697 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 500 | $62.24 | 155,197 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 1,798 | $62.25 | 153,399 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 6,400 | $62.25 | 146,999 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 2,931 | $62.26 | 144,068 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 4,613 | $62.26 | 139,455 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 2,501 | $62.27 | 136,954 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 5,660 | $62.27 | 131,294 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 1,340 | $62.28 | 129,954 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 400 | $62.28 | 129,554 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 600 | $62.29 | 128,954 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-31 | 100 | $62.29 | 128,854 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2018-01-31 | 27,733 | $0.00 | 27,733 | $22.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-02-18 | 2021-02-17 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.